文献速递冠心病心力衰竭与心肌病

氧疗对疑似急性心肌梗死患者死亡或心衰住院的长期影响

Long-Term Effects of Oxygen Therapy on Death or Hospitalization for Heart Failure in Patients With Suspected Acute Myocardial Infarction.
PubMed 文献 · Circulation · 2018-01-01

DETO2X-AMI试验比较了血氧正常疑似心梗患者接受吸氧或环境空气的效果,1年时无生存获益;本次报告预设次要终点:心血管死亡及全因死亡与心衰住院复合终点。共6629例患者随机分组,长期随访中位2.1年,两组复合终点和心血管死亡均无显著差异。

要点

  • 血氧正常疑似心梗患者常规吸氧未降低1年及长期全因死亡或心衰住院风险。
  • 长期随访中位2.1年,吸氧组与空气组心血管死亡无显著差异。
  • 住院期间急性心衰治疗、左室收缩功能及梗死面积两组相似。

核心结论

  • 血氧正常疑似心梗患者常规吸氧未减少1年内或长期随访的全因死亡与心衰住院复合终点或心血管死亡。

研究设计与样本

  • 实用主义、基于注册的随机临床试验,纳入6629例疑似急性心肌梗死且血氧饱和度≥90%的患者,随机接受6 L/min吸氧6-12小时(开放面罩)或环境空气。

主要发现

  • 1年内全因死亡或心衰住院:吸氧组8.0%,空气组7.9%(HR 0.99;95%CI 0.84-1.18;P=0.92)。
  • 长期随访(中位2.1年,范围1.0-3.7年)复合终点:吸氧组11.2%,空气组10.8%(HR 1.02;95%CI 0.88-1.17;P=0.84)。
  • 心血管死亡:吸氧组5.2%,空气组4.8%(HR 1.07;95%CI 0.87-1.33;P=0.52)。
  • 住院期间急性心衰治疗、超声评估左室收缩功能及高敏肌钙蛋白T测定的梗死面积两组相似。
  • 所有预设亚组结果一致。

临床怎么用

  • 对血氧饱和度≥90%的疑似急性心肌梗死患者,不应常规给予 supplemental oxygen。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In the DETO2X-AMI trial (Determination of the Role of Oxygen in Suspected Acute Myocardial Infarction), we compared supplemental oxygen with ambient air in normoxemic patients presenting with suspected myocardial infarction and found no significant survival benefit at 1 year. However, important secondary end points were not yet available. We now report the prespecified secondary end points cardiovascular death and the composite of all-cause death and hospitalization for heart failure. METHODS: In this pragmatic, registry-based randomized clinical trial, we used a nationwide quality registry for coronary care for trial procedures and evaluated end points through the Swedish population registry (mortality), the Swedish inpatient registry (heart failure), and cause of death registry (cardiovascular death). Patients with suspected acute myocardial infarction and oxygen saturation of ≥90% were randomly assigned to receive either supplemental oxygen at 6 L/min for 6 to 12 hours delivered by open face mask or ambient air. RESULTS: A total of 6629 patients were enrolled. Acute heart failure treatment, left ventricular systolic function assessed by echocardiography, and infarct size measured by high-sensitive cardiac troponin T were similar in the 2 groups during the hospitalization period. All-cause death or hospitalization for heart failure within 1 year after randomization occurred in 8.0% of patients assigned to oxygen and in 7.9% of patients assigned to ambient air (hazard ratio, 0.99; 95% CI, 0.84–1.18; P=0.92). During long-term follow-up (median [range], 2.1 [1.0–3.7] years), the composite end point occurred in 11.2% of patients assigned to oxygen and in 10.8% of patients assigned to ambient air (hazard ratio, 1.02; 95% CI, 0.88–1.17; P=0.84), and cardiovascular death occurred in 5.2% of patients assigned to oxygen and in 4.8% assigned to ambient air (hazard ratio, 1.07; 95% CI, 0.87–1.33; P=0.52). The results were consistent across all predefined subgroups. CONCLUSIONS: Routine use of supplemental oxygen in normoxemic patients with suspected myocardial infarction was not found to reduce the composite of all-cause mortality and hospitalization for heart failure, or cardiovascular death within 1 year or during long-term follow-up. CLINICAL TRIAL REGISTRATION: URL: https://www.clinicaltrials.gov. Unique identifier: NCT01787110.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Jernberg T, Lindahl B, Alfredsson J, et al. Long-Term Effects of Oxygen Therapy on Death or Hospitalization for Heart Failure in Patients With Suspected Acute Myocardial Infarction. Circulation. 2018. PMID: 30767504

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。